STERIS plc

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Assenagon Asset Management S.A. Increases Stake in STERIS plc $STE

AI-generated analysis

πŸ“ˆ Assenagon Asset Management raised its STERIS stake by 160.6% in Q1, adding 30,104 shares to a total holding of 48,846 shares.

🏦 Norges Bank initiated a new position valued at $320.3 million in the fourth quarter, signaling major institutional interest.

πŸ“Š AQR Capital Management increased its stake by 178.6% to own 1.18 million shares worth $291.7 million.

πŸ’° Boston Partners purchased a new stake valued at approximately $159 million in the third quarter.

πŸ“‰ Orbis Allan Gray Ltd boosted its position by 36% to hold 2.1 million shares valued at $504.5 million.

πŸ›οΈ State Street Corp increased its holdings by 6% in Q4, now owning 4.6 million shares worth $1.17 billion.

πŸ“ˆ Institutional ownership of STERIS stands at a high 94.69%, reflecting broad investor confidence.

πŸ’΅ The company paid a quarterly dividend of $0.63 per share on June 26th with an annualized yield of 1.2%.

πŸ“‰ VP John Adam Zangerle sold 1,419 shares for $296,968 under a pre-arranged trading plan on June 15th.

πŸ“‰ Director Richard C. Breeden sold 1,481 shares for $310,284 on June 2nd under a similar trading plan.

πŸ“Š Insider selling totaled 7,328 shares valued at $1.55 million over the last three months.

🎯 Analyst consensus rating is 'Moderate Buy' with an average price target of $278.00.

Bullish Signals
  • Major institutional investors including Norges Bank, AQR Capital Management, and Boston Partners have initiated or significantly increased their stakes in STERIS.
  • Assenagon Asset Management raised its position by 160.6% in the first quarter, demonstrating strong conviction in the company's prospects.
  • State Street Corp boosted its stake by 6% in the fourth quarter, adding to a substantial existing holding of over $1.1 billion.
  • The company maintains a healthy balance sheet with a current ratio of 2.09 and a low debt-to-equity ratio of 0.25.
  • STERIS pays a consistent quarterly dividend with an annualized yield of 1.2% and a payout ratio of 31.78%, indicating sustainable cash flow.
Risk Factors
  • VP John Adam Zangerle sold 1,419 shares for $296,968 in mid-June, representing a 3.87% decrease in his personal position.
  • Director Richard C. Breeden sold 1,481 shares for $310,284 on June 2nd, reducing his ownership by 3.66%.
  • Insiders collectively sold 7,328 shares valued at $1.55 million over the last three months, though this represents only 1.12% of total stock.
Full Analysis
Assenagon Asset Management S.A. significantly increased its stake in STERIS plc (NYSE:STE) by 160.6% during the first quarter, purchasing an additional 30,104 shares to hold a total of 48,846 shares valued at $10.8 million. This move aligns with other major institutional investors who have recently added to their positions, including Norges Bank which established a new stake worth over $320 million in the fourth quarter, and AQR Capital Management which raised its holdings by 178.6%. Other notable institutional activity includes Boston Partners initiating a position valued at approximately $159 million and Orbis Allan Gray Ltd boosting its stake by 36%. State Street Corp also increased its position by 6% in the fourth quarter. Collectively, these investors hold 94.69% of the company's outstanding stock, indicating strong institutional confidence in the medical equipment provider. STERIS shares are currently trading with a market capitalization of $21.01 billion and a price-to-earnings ratio of 27.19. The company recently paid a quarterly dividend of $0.63 per share to investors of record on June 8th, resulting in an annualized yield of 1.2%. Analyst consensus remains moderately bullish with an average price target of $278.00, though recent ratings from KeyCorp and Wall Street Zen have been adjusted slightly downward. Despite the strong institutional buying, insider selling activity was recorded in mid-June. VP John Adam Zangerle sold 1,419 shares for approximately $297,000 on June 15th, while Director Richard C. Breeden sold 1,481 shares for about $310,000 on June 2nd. These transactions were executed under pre-arranged Rule 10b5-1 trading plans and represent a small fraction of total insider ownership, which stands at 1.12%.